Hardin Capital Partners Q2 2026 Portfolio Activity: Focus on Value Stocks
This analysis details observable purchases and sales by Hardin Capital Partners in their portfolio during the second quarter of 2026, highlighting key holdings like LOW and BAC.
Hardin Capital Partners' portfolio saw significant changes this quarter as reported on InsiderSet. The firm's focus appears to be centered around value-oriented investments, evidenced by both new positions and increased stakes in established companies.
Among the most notable additions were several Vanguard fund holdings. Hardin Capital Partners significantly boosted their position in Vanguard Admiral Fund (VIOV), increasing shares by 74.68%. Similarly, they added substantially to the holding of Vanguard Index Fund (VO) with a nearly 315% increase in shares.
The investor also initiated new positions this quarter. This includes a fresh stake in the highly concentrated LOWES Cos Inc (LOW), which now represents 43.57% of their portfolio, and significant purchases of shares in Bank of America Corp (BAC) despite a slight reduction later.
In the Consumer Cyclical sector, Hardin Capital Partners made notable moves. They initiated a large position in ARHAUS Inc (ARHS), acquiring all shares from the previous quarter (+100%). Additionally, they increased their stake significantly in SCHWAB Strategic Trust (SCHX) by 23.42%.
The investor also deepened exposure to other cyclical stocks, notably increasing their position in Clorox Co Del (CLX) by acquiring shares that pushed the allocation percentage up. Conversely, they reduced their stake in TERAWULF Inc (WULF), a holding within Financial Services.
In summary, Hardin Capital Partners demonstrated active management during Q2 2026. They established new positions in funds like VIOV and VO, increased stakes in individual stocks such as LOWES and Clorox, while also reducing exposure to some holdings like TERAWULF. Their portfolio continues to be dominated by a large position in LOWES.